Chronic inflammation may cause long COVID — and could be the secret to treatment, new study says

“It’s possible they’re both correct,” said Dr. Dan Barouch, an author of the study and director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center.

But what excites Barouch about the chronic inflammation hypothesis is that several anti-inflammatory drugs already exist. Based on the study’s data, Barouch said Beth Israel Deaconess Medical Center has started a clinical trial with one such drug — abrocitinib, which is used to treat eczema. Read Full Article…